The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies. This is because linear RNA molecules have a fleeting existence inside cells-which is not a problem for it’s function as vaccine, but for other therapeutic applications longer existence is preferable. This is where the circular RNAS come in.